Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-06T06:24:32.321Z Has data issue: false hasContentIssue false

What are the long-term effects of treatment on survivors of childhood leukaemia? A review of the literature

Published online by Cambridge University Press:  23 August 2013

D. Whitaker*
Affiliation:
Department of Radiotherapy, St James University Hospital, Leeds, UK
D. Green
Affiliation:
Faculty of Health and Wellbeing, Sheffield Hallam University, Sheffield, UK
*
Correspondence to: Danielle Whitaker, Department of Radiotherapy, St James University Hospital, Leeds LS9 7TF, UK. Tel: 0113 2067472. E-mail: Danielle.Whitaker@Leedsth.nhs.uk
Rights & Permissions [Opens in a new window]

Abstract

Purpose

Key advances in cancer treatment have led to an increasing number of long-term cancer survivors. Knowledge of the long-term effects of cancer treatment on leukaemia survivors is to some degree limited. This article investigates the effects of the treatment of childhood leukaemia on the quality of life (QOL), the physical and the psychological wellbeing and general development of survivors. This article reviews current literature to examine existing gaps in knowledge and identify a potential focus of future research and clinical practice.

Materials and methods

Online systematic searching, along with historical searching took place in order to retrieve relevant primary research papers for the review. Strict inclusion and exclusion criteria were applied to the literature, to create a manageable amount of research papers.

Results

The extent of intellectual impairment among radiotherapy patients was significantly greater than those treated with chemotherapy only. Body composition, including endocrine function, is readily affected by cancer treatment. Early identification and interventions can greatly improve the QOL of survivors.

Conclusion

Further research into the effect of treatment modality on the extent of chronic effects, along with investigations into the needs of the whole family unit, is required. Future practice must take into account long-term implications while ensuring effective holistic care.

Type
Literature Reviews
Copyright
Copyright © Cambridge University Press 2013 

Introduction

The development of effective paediatric cancer treatments has drastically improved survival rates.Reference Ribeiro and Pui1Reference Hunger4 An increase in 5-year survival from <5% in the 1950s, to >75% in 2004, indicates the progress made.Reference Bradwell5 A consequence of these increased survival rates has been a subsequent research focus on the long-term effects of paediatric cancerReference Berg, Nuefeld, Harvey, Downes and Hayashi6, Reference Ness, Gurney and Zeltzer7 and an emphasis on prolonged monitoring and support of survivors to enable effective management of quality of life (QOL) issues.Reference Freyer and Kibrick-Lazear8

Leukaemia is the most common malignancy in childrenReference Shah and Coleman9 but with the introduction of enhanced treatment regimes, cure rates of almost 80% have been achieved for childhood acute lymphoblastic leukaemia (ALL).Reference Bowers, Liu and Leisenring10, Reference Pui, Campana and Pei11 Treatment for leukaemia can involve; chemotherapy, radiotherapy, bone marrow/stem cell transplants and steroids. Each modality has different implications for the future health and development of patients; therefore, the impact of each modality must be recognised, to enable well informed treatment decisions.Reference Bowers, Liu and Leisenring10 With the benefits of specific treatments being well established, the potential of long-term effects and their management need to be taken into account.

The volume of current research regarding the chronic health and psychological problems faced by survivors of childhood leukaemia is steadily increasing. This is due to the improvement in aforementioned survival rates, which enables a greater number of participants to be recruited into research studies.Reference Hunger4

The previous lack of research participants reduced the opportunity for longitudinal research needed to establish true long-term issues.Reference Van Der Lee, Wesseling, Tanck and Offringa12 As survival rates continue to improve, there will be increasing numbers of available participants for future research. Currently, the knowledge base is developing, and a variety of primary research papers are exploring this topic.Reference Daams, Schuitema and Van Dijk13Reference Fulbright, Raman, McClellan and August15

This article aims to assess information on the chronic effects of treatment on childhood survivors of leukaemia. It will consider the physical, psychological and developmental effects of treatment and their management.

QOL

Survivors of childhood cancer are faced with multiple long-term effects which can greatly impact upon their QOL.Reference Zelter, Lu and Leisenring16 Around two-thirds of survivors experience at least one long-term problem, while a quarter face a severe or life threatening late effect.Reference Bhatia and Landier17 A number of studies highlight the relationship between treatment modality, age at diagnosis and the extent of long-term problems.Reference Daams, Schuitema and Van Dijk13, Reference Fulbright, Raman, McClellan and August15, Reference Oeffinger, Nathan and Kremer18, Reference Dietz and Mulrooney19 Chronic side effects in young patients treated with cranial irradiation appear to be exacerbated, with there being fewer chronic side effects noted between chemotherapy regimes.Reference Spiegler, Kennedy and Maze20

With all cancer treatment there is the risk of acute and chronic side effects that may impact on a patient's QOL. Therefore, understanding the risks associated with cancer therapies is the first step in improving future care.Reference Bradley Eilertsen, Jozefiak, Rannestad, Indredavik and Vik21Reference Redaelli, Stephens, Brandt, Botteman and Pashos23

Methodology

An online literature search was performed. Combinations of search terms were used within this search, with the aim of collating the most relevant and up to date research papers. Table 1 displays the chosen search terms used.

Table 1 Brainstorm of search terms

In order to retain a manageable selection of research papers to review, inclusion and exclusion criterion were applied; creating a volume of appropriate literature.

Results

Physical effects

Endocrine system

The endocrine system is readily affected by cancer treatments, resulting in numerous long-term problems.Reference Duffner24 The extent of these problems appears to be directly related to the treatment modality, with endocrine problems rarely seen in those treated with chemotherapy only. In contrast, leukaemia patients treated with total body irradiation (TBI) and bone marrow transplants (BMT) often experience late endocrine disorders.Reference Steffens, Beauloye and Brichard25 Severe growth hormone deficiency (GHD) was seen in 50% of those treated with TBI and BMT, with 56% experiencing thyroid dysfunction (mainly hypothyroidism). Steffens et al.Reference Steffens, Beauloye and Brichard25 also found that 40% of males had biological signs of altered spermatogenesis, with all of the females treated with TBI and BMT having ovarian failure. The majority of patients studied were on some form of hormone replacement therapy with the aim of improving QOL. Close long-term follow up, regarding endocrine function, is regarded as essential in ensuring survivors are well supported.Reference Duffner24Reference Baronio, Battist and Radetti27

Body composition

Ness et al.Reference Ness, Baker and Dengal28 found the percentage fat mass of leukaemia survivors was significantly higher than the expected norms, with percentage skeletal and lean body mass significantly lower. In contrast, Murphy et al.Reference Murphy, Wells, Williams, Fewtrell, Davies and Webb29 also established there to be a significant difference in percentage fat mass between survivors and control subjects, but no difference in relation to treatment type. Body mass index (BMI) has been found to be significantly higher in female survivors when compared with both the expected norms, and control subjects.Reference Garmey, Liu and Sklar30 Females treated with high dose cranial irradiation (10–20 Gy), at a young age were found to have a mean BMI increase of 0·41 units per year.Reference Razzouk, Rose and Hongend31 Male survivors also demonstrated higher BMIs indicating weight problems. However, male control subjects also displayed signs of being overweightReference Garmey, Liu and Sklar30; therefore, the effect of cancer treatment on male survivors’ body composition was not established.

In terms of bone mineral density (BMD), there were no differences between cases and controls, apart from lumbar spine bone density, which was significantly lower in survivors.Reference Jarfelt, Fors, Lannering and Bjarnason32 No difference in BMD was found between groups who received cranial irradiation, and those who did not.Reference Jarfelt, Fors, Lannering and Bjarnason32 This information, coupled with the BMI data, highlights the need for childhood survivors, especially female, to be given guidance on healthy lifestyles in the long term to reduce the occurrence of obesity.

Physical ability

As a result of higher percentage fat masses, and lower BMD in some cases, problems with mobility and strength have been detected. Knee extension strength in particular is significantly lower in leukaemia survivors than the expected norms and control groups tested.Reference Van Brussel, Takken and Net33 As a result, survivors walked significantly shorter distances in 2 minutes, demonstrating their impaired mobility.Reference Ness, Baker and Dengal28 Cranial irradiation was found to reduce strength and mobility, particularly in female survivors. One explanation for reduced mobility could be the effect radiation treatment has on motor nerve conduction.Reference Ness, Hudson and Pui34 This study identified a significant difference regarding motor nerve conduction and lower extremities, resulting in limitations of ankle movements and distal muscle weakness. Survivors’ balance was also affected by treatment somewhat, with one-third of patients unable to complete the most challenging task.Reference Galea, Wright and Barr35 Balance problems became clear when vision was removed, and survivors were tested with uneven surfaces. These problems pose a potential threat to survivors in terms of physical activity.

Physical activity during childhood and adolescent years is very important due to its protective effect on body composition and overall general health.Reference Florin, Fryer and Miyoshi36 Florin et al.Reference Florin, Fryer and Miyoshi36 found survivors had significantly lower physical activity scores than current recommended standards; those treated with cranial irradiation (>20 Gy) being most affected. Jarfelt et al.Reference Jarfelt, Fors, Lannering and Bjarnason32 noted male survivors previously treated with cranial irradiation, especially with existing GHD, experienced much lower exercise capacities, with no differences seen between female groups. Both aerobic and anaerobic exercise capacity have been seen to be reduced in leukaemia survivors, along with self-reported cardio-pulmonary fitness levels.Reference Ness, Baker and Dengal28 This would seem to suggest that patient education and compliance in terms of physical activity could reduce the negative effects of cancer treatment on physical fitness and function. However, the subjects in the study by Heath, Ramzy and Donath,Reference Heath, Ramzy and Donath3 met or exceeded national standards for physical activity, with the exception of three children out of 19.

Psychological and developmental effects

Cranial irradiation has been shown to increase the extent of neurocognitive impairment.Reference Harila, Winqvist, Lanning, Bloigu and Harila-saari37 When compared with a chemotherapy only group, those previously treated with radiotherapy scored lower in tests for verbal intelligence quotient (IQ), attention and concentration ability, and memory. Spiegler et al.Reference Spiegler, Kennedy and Maze20 noted survivors treated with radiation scored significantly lower in arithmetic and reading/comprehension tests, whereas differences in attention and intellect were not detected.Reference Reddick, Shan and Glass38 This suggests that prophylactic cranial irradiation increases the risk of survivors experiencing neuropsychological impairment, resulting in certain cognitive and intellectual deficits.Reference Harila, Winqvist, Lanning, Bloigu and Harila-saari37 Reduced volumes of white matter correspond to a greater deficit in intelligence and academic achievement, as a result of both cranial irradiation, and chemotherapy to a lesser extent.Reference Reddick, Shan and Glass38

With regards to patients treated with chemotherapy only; selective aspects of cognitive functioning are impaired, especially visual processing.Reference Mennes, Stiers and Vandenbussche39 Intensified courses of chemotherapy have been seen to cause extensive deficits regarding attentional flexibility, and visuo-motor control.Reference Buizer, De Sonneville, Van Der Heuvel-Eibrink and Veerman40 Those diagnosed at a younger age appear more likely to be affected by certain deficits; however, it is unclear as to whether this is as a result of a greater susceptibility to chemotherapy drugs.Reference Jansen, Kingma and Schuitema41 Although chemotherapy appeared to have little consequences concerning intellectual functioning, two young patients out of 21 did show a decline of >10 IQ points. However, greater educational support has been shown to reduce these effects on a survivor's intellectual functioning, thus such interventions can be effective.Reference Mennes, Stiers and Vandenbussche39

Following the completion of the Strength and Difficulties Questionnaire for children, no statistically significant differences in psychosocial health were seen.Reference Reinfjell, Lofstad, Nordahl, Vikan and Diseth42 Link et al.Reference Link, Moëll and Osterberg43 found there to be no differences in self-reported QOL, yet a significantly lower level of education was reached. Only 23% of survivors reached university level, in comparison to 55% of healthy controls. In contrast, Reinfjell et al.Reference Reinfjell, Lofstad, Veenstra, Vikan and Diseth44 concluded that there was a significantly lower health-related QOL among survivors of leukaemia when compared with healthy controls. Intellectual functioning was determined to be within the normal range, but lower than that of the control group. These differences in self-reported QOL and intellectual functioning need to be investigated further, to enable the early detection of indicators relating to a declination of psychosocial wellbeing from the norm.

With greater than two-thirds of children diagnosed with cancer achieving disease free survival, it is essential to be aware of the long-term effects which may arise.Reference Quin45 Early detection and interventions can improve the QOL of both cancer survivors and their family by relieving pressures and reducing the extent of problems.Reference Zelter, Lu and Leisenring16 Where cure is the aim, it is also necessary that the potential chronic issues do not outweigh the advantages. Treatment modality does play a part in the chronic effects experienced, therefore treatment plans need to be discussed in depth to provide the best care for each patient.Reference Temming and Jenney46

Conclusion

The majority of the research papers focused on survivors of ALL and did not include other types of leukaemia such as acute myeloid leukaemia and chronic myeloid leukaemia. These forms of leukaemia are rarer thus the research available is limited. Nevertheless, it is important to investigate whether differences exist between the long-term effects for the different types of leukaemia to determine the optimum post treatment care.

As a result of the critical analysis of this literature review, it is clear that childhood survivors of leukaemia face many chronic side effects that impact upon their QOL. This is currently an inevitable consequence of curative treatment received. This highlights the importance of long-term follow up, especially for those diagnosed at a young age.Reference Quin45 There are clear relationships between the extent of chronic effects, and the treatment modality, with cranial irradiation and TBI causing greater impairments.Reference Steffens, Beauloye and Brichard25 Further research into this area is required to enable health professionals to shape the treatment of paediatrics, with the aim of providing them with the best QOL possible. Future practice must be concerned with long-term QOL as well as curing the short-term problem.

Financial Support

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Conflicts of Interest

None.

References

1.Ribeiro, R C, Pui, C. Saving the children—improving childhood cancer treatment in developing countries. N Engl J Med 2005; 352 (21): 21582160.CrossRefGoogle ScholarPubMed
2.Cantrell, M A, Ruble, K. Multidisciplinary care in paediatric oncology. J Multidiscip Healthc 2011; 4 (1): 171181.CrossRefGoogle Scholar
3.Heath, J A, Ramzy, J M, Donath, S M. Physical activity in survivors of childhood acute lymphoblastic leukaemia. J Paediatr Child Health 2010; 46 (4): 149153.CrossRefGoogle ScholarPubMed
4.Hunger, S P. Improved survival for children and adolescents with acute lymphoblastic leukaemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol 2012; 30 (14): 16631669.CrossRefGoogle ScholarPubMed
5.Bradwell, M. Survivors of childhood cancer. Paediatr Nurs 2009; 21 (4): 2124.CrossRefGoogle ScholarPubMed
6.Berg, C, Nuefeld, P, Harvey, J, Downes, A, Hayashi, R J. Late effects of childhood cancer, participation, and quality of life of adolescents. OTJR 2009; 29 (3): 116124.Google Scholar
7.Ness, K K, Gurney, J G, Zeltzer, L Ket al. The impact of limitations in physical, executive and emotional function on health related quality of life among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Arch Phys Med Rehabil 2008; 89 (1): 128136.CrossRefGoogle ScholarPubMed
8.Freyer, D R, Kibrick-Lazear, R. In sickness and in health. Cancer 2006; 107 (suppl 7), 17021709.CrossRefGoogle ScholarPubMed
9.Shah, A, Coleman, M P. Increasing incidence of childhood leukaemia: a controversy re-examined. Br J Cancer 2007; 97 (7): 10091012.CrossRefGoogle ScholarPubMed
10.Bowers, D C, Liu, Y, Leisenring, Wet al. Late-occurring stroke among long-term survivors of childhood leukaemia and brain tumours: a report from the childhood cancer survivor study. J Clin Oncol 2006; 24 (33): 52775282.CrossRefGoogle ScholarPubMed
11.Pui, C H, Campana, D, Pei, Det al. Treating childhood acute lymphoblastic leukaemia without cranial irradiation. N Engl J Med 2009; 360 (26): 27302741.CrossRefGoogle ScholarPubMed
12.Van Der Lee, J H, Wesseling, J, Tanck, M W T, Offringa, M. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases. J Clin Epidemiol 2008; 61 (4): 324330.CrossRefGoogle ScholarPubMed
13.Daams, M, Schuitema, I, Van Dijk, B Wet al. Long-term effects of cranial irradiation and intrathecal chemotherapy in treatment of childhood leukaemia: a MEG study of power spectrum and correlated cognitive dysfunction. BMC Neurol 2012; 12 (1): 84.CrossRefGoogle ScholarPubMed
14.Mud, M S, Kremer, L C, Sieswerda, E, Van Der Pal, H J. Care for survivors of childhood cancer in the Netherlands. Ned Tijdschr Geneeskd 2012; 156 (9): A4199.Google ScholarPubMed
15.Fulbright, J M, Raman, S, McClellan, W S, August, K J. Late effects of childhood leukaemia therapy. Curr Hematol Malig Rep 2011; 6 (3): 195205.CrossRefGoogle Scholar
16.Zelter, L K, Lu, Q, Leisenring, Wet al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 2008; 17 (2): 435446.CrossRefGoogle Scholar
17.Bhatia, S, Landier, W. Evaluating survivors of paediatric cancer. Cancer J 2005; 11 (4): 340354.CrossRefGoogle Scholar
18.Oeffinger, K C, Nathan, P C, Kremer, L C M. Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Hematol Oncol Clin North Am 2010; 24 (1): 129149.CrossRefGoogle ScholarPubMed
19.Dietz, A C, Mulrooney, D A. Life beyond the disease: relationships, parenting and quality of life among survivors of childhood cancer. Haematologica 2011; 96 (5): 643645.CrossRefGoogle ScholarPubMed
20.Spiegler, B J, Kennedy, K, Maze, Ret al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukaemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006; 24 (24): 38583864.CrossRefGoogle ScholarPubMed
21.Bradley Eilertsen, M E, Jozefiak, T, Rannestad, T, Indredavik, M S, Vik, T. Quality of life in children and adolescents surviving cancer. Eur J Oncol Nurs 2012; 16 (2): 185193.CrossRefGoogle ScholarPubMed
22.Levin, T T, Li, Y, Riskind, J, Rai, K. Depression, anxiety and quality of life in chronic lymphocytic leukaemia cohort. Gen Hosp Psychiatry 2007; 29 (1): 251256.CrossRefGoogle Scholar
23.Redaelli, A, Stephens, J M, Brandt, S, Botteman, M F, Pashos, C L. Short and long-term effects of acute myeloid leukaemia on patient health-related quality of life. Cancer Treat Rev 2004; 30 (1): 103117.CrossRefGoogle Scholar
24.Duffner, P K. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumours. Neurologist 2004; 10 (6): 293310.CrossRefGoogle Scholar
25.Steffens, M, Beauloye, V, Brichard, Bet al. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol 2008; 69 (5): 819827.CrossRefGoogle ScholarPubMed
26.Thomas, I H. Bone mineral density in young adult survivors of acute lymphoblastic leukaemia. Cancer 2008; 113 (11): 32483256.CrossRefGoogle Scholar
27.Baronio, F, Battist, L, Radetti, G. Central hypothyroidism following chemotherapy for acute lymphoblastic leukaemia. J Paediatr Endocrinol Metab 2011; 24 (11–12): 903906.CrossRefGoogle Scholar
28.Ness, K K, Baker, K S, Dengal, D Ret al. Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukaemia. Paediatr Blood Cancer 2006; 49 (7): 975981.CrossRefGoogle Scholar
29.Murphy, A J, Wells, J C K, Williams, J E, Fewtrell, M S, Davies, P S W, Webb, D K. Body composition in children in remission from acute lymphoblastic leukaemia. Am J Clin Nutr 2006; 83 (1): 7074.CrossRefGoogle Scholar
30.Garmey, E G, Liu, Q, Sklar, C Aet al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukaemia: a report from the childhood cancer survivor study. J Clin Oncol 2008; 26 (28): 46394645.CrossRefGoogle ScholarPubMed
31.Razzouk, B I, Rose, S R, Hongend, Set al. Obesity in survivors of childhood acute lymphoblastic leukaemia and lymphoma. J Clin Oncol 2007; 25 (10): 11831189.CrossRefGoogle Scholar
32.Jarfelt, M, Fors, H, Lannering, B, Bjarnason, R. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 2006; 154 (2): 303309.CrossRefGoogle ScholarPubMed
33.Van Brussel, M, Takken, T, Net, J V Det al. Physical function and fitness in long-term survivors of childhood leukaemia. Paediatr Rehabil 2006; 9 (3): 267274.CrossRefGoogle ScholarPubMed
34.Ness, K K, Hudson, M M, Pui, C H. Neuromuscular impairment in adult survivors of childhood acute lymphoblastic leukaemia: associations with physical performance and chemotherapy doses. Cancer 2012; 118 (3): 828838.CrossRefGoogle ScholarPubMed
35.Galea, V, Wright, M J, Barr, R D. Measurement of balance in survivors of acute lymphoblastic leukaemia in childhood. Gait Posture 2004; 19 (1): 110.CrossRefGoogle ScholarPubMed
36.Florin, T A, Fryer, G E, Miyoshi, Tet al. Physical inactivity in adult survivors of childhood acute lymphoblastic leukaemia: a report from the childhood cancer survivor study. Cancer Epidermiol Biomarkers Prev 2007; 16 (7): 13561363.CrossRefGoogle ScholarPubMed
37.Harila, M J, Winqvist, S, Lanning, M, Bloigu, R, Harila-saari, A H. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 2009; 53 (2): 156161.CrossRefGoogle Scholar
38.Reddick, W E, Shan, Z Y, Glass, J Oet al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukaemia. Cancer 2006; 106 (4): 941949.CrossRefGoogle Scholar
39.Mennes, M, Stiers, P, Vandenbussche, Eet al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Paediatr Blood Cancer 2005; 44 (5): 479486.CrossRefGoogle ScholarPubMed
40.Buizer, A I, De Sonneville, L M, Van Der Heuvel-Eibrink, M M, Veerman, A J. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukaemia: effect of treatment intensity. Paediatr Blood Cancer 2005; 45 (3): 281290.CrossRefGoogle ScholarPubMed
41.Jansen, N C, Kingma, A, Schuitema, Aet al. Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: A prospective, sibling-controlled study. Eur J Cancer 2006; 42 (16): 27652772.CrossRefGoogle ScholarPubMed
42.Reinfjell, T, Lofstad, G E, Nordahl, H M, Vikan, A, Diseth, T H. Children in remission from acute lymphoblastic leukaemia: mental health, psychosocial adjustment and parental functioning. Eur J Cancer Care 2009; 18 (4): 364370.CrossRefGoogle ScholarPubMed
43.Link, K, Moëll, C, Osterberg, Ket al. Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation. Clin Endocrinol 2006; 65 (5): 617625.CrossRefGoogle ScholarPubMed
44.Reinfjell, T, Lofstad, G E, Veenstra, M, Vikan, A, Diseth, T H. Health-related quality of life and intellectual functioning in children in remission from acute lymphoblastic leukaemia. Acta Paediatrica 2007; 96 (9): 12801285.CrossRefGoogle ScholarPubMed
45.Quin, S. The long-term psychosocial effects of cancer diagnosis and treatment on children and their families. Soc Work Health Care 2004; 39 (1): 129149.CrossRefGoogle ScholarPubMed
46.Temming, P, Jenney, M E M. The neurodevelopmental sequelae of childhood leukaemia and its treatment. Arch Dis Child 2010; 95 (11): 936940.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Brainstorm of search terms